在心力衰竭中增加SGLT2抑制剂的数字实施策略:EMAIL-HF的研究设计
Mariam Elmegaard1, Lars Køber2,3, Mads Kristian Ersbøll2
1Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark.
ESC heart failure
|August 25, 2025
概括
在心力衰竭 (HF) 患者中,数字化策略有效地增加和加快了-葡萄糖共运输体2 (SGLT2) 抑制剂的启动. 这种方法为在日常护理中实施新疗法提供了一个可扩展的模型.
科学领域:
- 心脏病学
- 数字卫生实施
- 药物治疗
背景情况:
- 心力衰竭 (HF) 管理指南建议使用-葡萄糖辅运输体2 (SGLT2) 抑制剂.
- 及时启动指导药物治疗对于改善HF患者的结果至关重要.
- 在临床实践中采用新疗法往往会延迟.
研究的目的:
- 评估数字指南实施策略在增加和加速HF患者SGLT2抑制剂的有效性.
- 评估可扩展的数字模型的潜力,以改善新的高频疗法.
主要方法:
- EMAIL-HF试验是一项实用,基于注册的随机对照试验.
- 5996名不接受SGLT2抑制剂的符合条件的HF患者被随机分为1:1接受数字干预或常规护理.
- 主要结局是在6个月内启动SGLT2抑制剂;次要结局包括HF住院或全因死亡.
主要成果:
- 该研究旨在确定数字策略是否可以改善SGLT2抑制剂的吸收.
- 完整的基线特征和临床结果将在事件累积后报告.
- 该试验包括在过去10年内在丹麦被诊断出HF的患者.
结论:
- 该试验将确定全民数字化策略是否能提高慢性HF的SGLT2抑制剂启动.
- 这项研究可能为在常规临床实践中实施新疗法提供一个可扩展的模型.
- 这些研究结果将为加快心血管医学遵循指南的策略提供信息.
相关概念视频
Heart Failure V: Medical Management
23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
Heart Failure Drugs: Inotropic Agents
717
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
717
Heart Failure VI: Adjunct Therapies
27
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
27
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
505
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
505
Heart Failure Drugs: Diuretics
483
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
483
Heart Failure IV: Classification and Diagnostic Evaluation
32
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
32


